CDY3P

Across TCGA pan-cancer cohorts, CDY3P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated CDY3P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher CDY3P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CDY3P expression acts as an unfavorable survival marker.

BLCA, THYM, and STAD are the cancer types where CDY3P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.132	0.629	<.001	144	view →
THYM	OS	Tertile	All	0.169	0.931	<.001	72	view →
STAD	DFS	Tertile	All	0.401	0.666	.002	45	view →
OV	OS	Tertile	IV	0.059	0.759	.006	36	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
KIRP	DFS	Tertile	All	0.161	0.613	.002	12	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

CDY3P–BLCA (DFS)

Open the BLCA breakdown →